TW276256B - - Google Patents
Info
- Publication number
- TW276256B TW276256B TW083107595A TW83107595A TW276256B TW 276256 B TW276256 B TW 276256B TW 083107595 A TW083107595 A TW 083107595A TW 83107595 A TW83107595 A TW 83107595A TW 276256 B TW276256 B TW 276256B
- Authority
- TW
- Taiwan
- Prior art keywords
- insufficiency
- preventing
- surgery
- treating
- hydrogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21197293 | 1993-08-26 | ||
JP14812694 | 1994-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW276256B true TW276256B (zh) | 1996-05-21 |
Family
ID=26478451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW083107595A TW276256B (zh) | 1993-08-26 | 1994-08-19 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0640606B1 (zh) |
KR (1) | KR950005311A (zh) |
CN (1) | CN1106663A (zh) |
AT (1) | ATE208393T1 (zh) |
CA (1) | CA2130859A1 (zh) |
DE (1) | DE69428952T2 (zh) |
FI (2) | FI943912A (zh) |
HU (1) | HU218939B (zh) |
NO (1) | NO307565B1 (zh) |
RU (1) | RU2142275C1 (zh) |
TW (1) | TW276256B (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6140325A (en) * | 1993-08-19 | 2000-10-31 | Takeda Chemical Industries, Ltd. | Thienopyrimidine derivatives, their production and use |
US6048863A (en) | 1994-04-19 | 2000-04-11 | Takeda Chemical Industries, Ltd. | Condensed-ring thiophene derivatives and thienopyrimidine derivatives, their production and use |
UY23948A1 (es) * | 1995-02-08 | 2001-10-25 | Takeda Chemical Industries Ltd | Derivados de anillos condensados de tiofeno su producción y uso. |
CA2227384A1 (en) * | 1995-08-17 | 1997-02-27 | Toshifumi Watanabe | Thienopyrimidine derivatives, their production and use |
CA2192283A1 (en) * | 1995-12-08 | 1997-06-09 | Nobuhiro Suzuki | Prolactin production inhibitory agent |
US5828149A (en) * | 1996-07-18 | 1998-10-27 | Baker Hughes Incorported | Lubricant inducer pump for electrical motor |
WO1998018781A2 (en) * | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents |
US6025371A (en) * | 1996-10-28 | 2000-02-15 | Versicor, Inc. | Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones |
US6413724B1 (en) | 1996-10-28 | 2002-07-02 | Versicor, Inc. | Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones |
US6469014B1 (en) | 1997-05-28 | 2002-10-22 | Astrazeneca Ab | Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy |
US6984644B2 (en) | 1997-05-28 | 2006-01-10 | Astrazeneca Ab | Treatment of skin disorders using thieno[2,3-D]pyrimidinediones |
SE9702001D0 (sv) | 1997-05-28 | 1997-05-28 | Astra Pharma Prod | Novel compounds |
ES2211161T3 (es) * | 1998-08-28 | 2004-07-01 | Astrazeneca Ab | Tieno(2,3-d)pirimidindionas novedosas, procedimiento para su preparacion y uso de las mismas en terapia. |
HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
EP1280806B1 (en) * | 2000-05-04 | 2004-08-04 | AstraZeneca AB | THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
UA123760C2 (uk) * | 2011-11-11 | 2021-06-02 | Гіліад Аполло, Ллс | Сполука (варіанти) та композиція, що містить сполуку |
CN102920695B (zh) * | 2012-11-16 | 2014-08-06 | 蔡进 | 苯并呋喃类内皮素受体拮抗剂及用途 |
WO2016023832A1 (en) * | 2014-08-11 | 2016-02-18 | Hydra Biosciences, Inc. | Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders |
US12006328B2 (en) * | 2014-11-18 | 2024-06-11 | Emory University | Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto |
UY36586A (es) * | 2015-03-26 | 2016-10-31 | Bayer Pharma AG | Heterociclilmetiltienouracilos y uso de los mismos |
AR106472A1 (es) | 2015-10-26 | 2018-01-17 | Gilead Apollo Llc | Inhibidores de acc y usos de los mismos |
CN108347939B (zh) | 2015-11-25 | 2021-09-28 | 吉利德阿波罗公司 | 含有2,4-二氧代-1,4-二氢噻吩并[2,3-d]嘧啶的衍生物的杀真菌组合物 |
MX2018006288A (es) | 2015-11-25 | 2018-09-07 | Gilead Apollo Llc | Inhibidores de acc tipo ester y usos de los mismos. |
KR20180082556A (ko) | 2015-11-25 | 2018-07-18 | 길리어드 아폴로, 엘엘씨 | 피라졸 acc 억제제 및 그의 용도 |
JP2018536661A (ja) | 2015-11-25 | 2018-12-13 | ギリアド アポロ, エルエルシー | トリアゾールacc阻害剤およびその使用 |
BR112018067408A2 (pt) | 2016-03-02 | 2018-12-26 | Gilead Apollo Llc | formas sólidas de um inibidor de acc de tienopirimidinadiona e métodos para a produção das mesmas |
JP6906626B2 (ja) | 2017-03-28 | 2021-07-21 | ギリアード サイエンシーズ, インコーポレイテッド | 肝疾患を処置するための治療的組み合わせ |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02225485A (ja) * | 1989-02-27 | 1990-09-07 | Taiho Yakuhin Kogyo Kk | チエノピリミジン―3―酢酸誘導体 |
US5082838A (en) * | 1989-06-21 | 1992-01-21 | Takeda Chemical Industries, Ltd. | Sulfur-containing fused pyrimidine derivatives, their production and use |
CA2036618C (en) * | 1990-02-22 | 2002-10-29 | Akira Morimoto | Fused thiophene derivatives, their production and use |
-
1994
- 1994-08-19 TW TW083107595A patent/TW276256B/zh active
- 1994-08-24 DE DE69428952T patent/DE69428952T2/de not_active Expired - Fee Related
- 1994-08-24 AT AT94113169T patent/ATE208393T1/de not_active IP Right Cessation
- 1994-08-24 EP EP94113169A patent/EP0640606B1/en not_active Expired - Lifetime
- 1994-08-25 HU HU9402453A patent/HU218939B/hu not_active IP Right Cessation
- 1994-08-25 FI FI943912A patent/FI943912A/fi unknown
- 1994-08-25 CA CA002130859A patent/CA2130859A1/en not_active Abandoned
- 1994-08-25 NO NO943146A patent/NO307565B1/no not_active IP Right Cessation
- 1994-08-25 RU RU94030480A patent/RU2142275C1/ru active
- 1994-08-26 KR KR1019940021232A patent/KR950005311A/ko not_active Application Discontinuation
- 1994-08-26 CN CN94115719A patent/CN1106663A/zh active Pending
-
1999
- 1999-02-23 FI FI990387A patent/FI990387A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
EP0640606B1 (en) | 2001-11-07 |
NO943146D0 (no) | 1994-08-25 |
FI943912A0 (fi) | 1994-08-25 |
DE69428952D1 (de) | 2001-12-13 |
DE69428952T2 (de) | 2002-06-27 |
FI943912A (fi) | 1995-06-05 |
HUT71116A (en) | 1995-11-28 |
FI990387A0 (fi) | 1999-02-23 |
KR950005311A (ko) | 1995-03-20 |
NO307565B1 (no) | 2000-04-25 |
ATE208393T1 (de) | 2001-11-15 |
CA2130859A1 (en) | 1995-02-27 |
EP0640606A1 (en) | 1995-03-01 |
CN1106663A (zh) | 1995-08-16 |
HU218939B (hu) | 2001-01-29 |
HU9402453D0 (en) | 1994-10-28 |
NO943146L (no) | 1995-02-27 |
FI990387A (fi) | 1999-02-23 |
RU94030480A (ru) | 1996-10-10 |
RU2142275C1 (ru) | 1999-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW276256B (zh) | ||
EP1385823A4 (en) | NEW GUANIDINOVER BINDINGS | |
FI961510A (fi) | Kondesoidut pyridatsiinikoostumukset | |
LV12047A (lv) | Kondenseti pirimidina atvasinajumi un to lietosana par angiotenzina II antagonistiem | |
MX9704588A (es) | Derivados de aril- y hetaril-sulfonamida, su preparacion y su uso como antagonistas de la endotelina. | |
AU9281198A (en) | Benzofuran derivatives | |
ID24846A (id) | Turunan-turunan bifenilamidina | |
MXPA04004802A (es) | Derivados del 1,2,4-triazol que contienen un grupo sulfamato como inhibidores de aromatasa. | |
DE69422021D1 (en) | Morpholinderivate | |
SG50820A1 (en) | Novel thiouracil derivatives and metal surface- treating agent comprising thereof | |
TH45984A (th) | การรวมของสารยับยั้ง MTP และสารยับยั้งรีดักเตส HMG-CoA และการใช้ของสารเหล่านี้ในลักษณะที่เป็นยา |